<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">
Skip to content

 

Posters

 

 

Always at the forefront of the dynamic patient-derived xenograft (PDX) market, Champions Oncology has emerged as a respected key opinion leader on the utilization and benefits of PDX models in oncology drug development.

NEW! CYTO 2024 Posters
NEW! AACR 2024 Posters
Clinical Flow Cytometry
Hematological Malignancies
Humanized Models
Lumin Acuity
Solid Tumor PDX Models
TumorGraft3D & Co-Culture Platforms